CryoLife Shares Outstanding 2006-2018 | CRY

CryoLife shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CryoLife Annual Shares Outstanding
(Millions of Shares)
2018 36
2017 34
2016 33
2015 29
2014 28
2013 28
2012 27
2011 28
2010 28
2009 28
2008 28
2007 27
2006 25
2005 24
CryoLife Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 36
Q3 2018 38
Q2 2018 37
Q1 2018 36
Q4 2017 34
Q3 2017 34
Q2 2017 34
Q1 2017 34
Q4 2016 33
Q3 2016 33
Q2 2016 33
Q1 2016 32
Q4 2015 29
Q3 2015 29
Q2 2015 28
Q1 2015 28
Q4 2014 28
Q3 2014 28
Q2 2014 28
Q1 2014 28
Q4 2013 28
Q3 2013 28
Q2 2013 27
Q1 2013 27
Q4 2012 27
Q3 2012 27
Q2 2012 27
Q1 2012 28
Q4 2011 28
Q3 2011 28
Q2 2011 28
Q1 2011 28
Q4 2010 28
Q3 2010 28
Q2 2010 28
Q1 2010 29
Q4 2009 28
Q3 2009 28
Q2 2009 28
Q1 2009 28
Q4 2008 28
Q3 2008 29
Q2 2008 28
Q1 2008 28
Q4 2007 27
Q3 2007 28
Q2 2007 26
Q1 2007 26
Q4 2006 25
Q3 2006 25
Q2 2006 25
Q1 2006 25
Q4 2005 24
Q3 2005 24
Q2 2005 24
Q1 2005 24
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.089B $0.263B
CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $106.119B 23.92
Intuitive Surgical (ISRG) United States $64.916B 60.64
Edwards Lifesciences (EW) United States $39.343B 40.29
Fresenius Medical Care AG KGaA (FMS) Germany $24.388B 16.70
IDEXX Laboratories (IDXX) United States $18.775B 51.12
ABIOMED (ABMD) United States $15.300B 101.00
Teleflex (TFX) United States $13.871B 30.42
Hologic (HOLX) United States $13.817B 20.89
DexCom (DXCM) United States $13.225B 506.69
Varian Medical Systems (VAR) United States $12.404B 30.98
STERIS (STE) United Kingdom $10.430B 26.81
Masimo (MASI) United States $7.078B 44.07
Penumbra (PEN) United States $5.361B 303.31
Integra LifeSciences Holdings (IART) United States $4.828B 23.41
Globus Medical (GMED) United States $4.715B 28.62
LivaNova (LIVN) United Kingdom $4.639B 28.36
Tandem Diabetes Care (TNDM) United States $4.153B 0.00
Wright Medical Group (WMGI) Netherlands $4.065B 0.00
Cantel Medical (CMD) United States $2.808B 27.93
Integer Holdings (ITGR) United States $2.794B 22.80
Glaukos (GKOS) United States $2.717B 0.00
Inogen (INGN) United States $2.097B 41.79
AVANOS MEDICAL, INC (AVNS) United States $2.029B 22.04
OPKO Health (OPK) United States $1.545B 0.00
Nevro (NVRO) United States $1.360B 0.00
Tactile Systems Technology (TCMD) United States $1.156B 219.50
Pacific Biosciences Of California (PACB) United States $1.111B 0.00
Luminex (LMNX) United States $1.096B 50.08
ORTHOFIX MEDICAL INC (OFIX) United States $1.083B 29.43
Accelerate Diagnostics (AXDX) United States $1.082B 0.00
Intersect ENT (XENT) United States $1.023B 0.00
Veracyte (VCYT) United States $0.906B 0.00
Natus Medical (BABY) United States $0.904B 18.84
Mesa Laboratories (MLAB) United States $0.892B 36.47
AngioDynamics (ANGO) United States $0.822B 26.67
AxoGen (AXGN) United States $0.814B 0.00
ViewRay (VRAY) United States $0.783B 0.00
OrthoPediatrics (KIDS) United States $0.688B 0.00
Quotient (QTNT) Switzerland $0.598B 0.00
Fluidigm (FLDM) United States $0.564B 0.00
TransEnterix (TRXC) United States $0.484B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.475B 50.03
Corindus Vascular Robotics (CVRS) United States $0.466B 0.00
Si-Bone (SIBN) United States $0.461B 0.00
Accuray (ARAY) United States $0.423B 0.00
GenMark Diagnostics (GNMK) United States $0.418B 0.00
Pulse Biosciences (PLSE) United States $0.390B 0.00
RTI Surgical (RTIX) United States $0.368B 53.73
Neuronetics (STIM) United States $0.316B 0.00
IRadimed (IRMD) United States $0.281B 59.51
SeaSpine Holdings (SPNE) United States $0.276B 0.00
Sientra (SIEN) United States $0.257B 0.00
Nuvectra (NVTR) United States $0.219B 0.00
CRH Medical (CRHM) Canada $0.203B 47.17
Helius Medical Technologies (HSDT) United States $0.164B 0.00
Ekso Bionics Holdings (EKSO) United States $0.161B 0.00
ConforMIS (CFMS) United States $0.145B 0.00
Biosig Technologies (BSGM) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.126B 0.00
Alphatec Holdings (ATEC) United States $0.118B 0.00
T2 Biosystems (TTOO) United States $0.113B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
SOLITON INC (SOLY) $0.107B 0.00
Vermillion (VRML) United States $0.100B 0.00
EDAP TMS (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.049B 0.00
Electromed (ELMD) United States $0.046B 23.87
Avinger (AVGR) United States $0.044B 0.00
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
OBALON THERPTCS (OBLN) United States $0.038B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Restoration Robotics (HAIR) United States $0.032B 0.00
Viveve Medical (VIVE) United States $0.031B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
Atossa Genetics (ATOS) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.020B 63.33
ENDRA Life Sciences (NDRA) United States $0.019B 0.00
Dynatronics (DYNT) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Presbia (LENS) Ireland $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.016B 11.87
Nanovibronix (NAOV) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.013B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00